Fosun Pharma secures $3.5m to accelerate development of malaria therapy

Fosun Pharma secures $3.5m to accelerate development of malaria therapy

Submitted by admin on December 14, 2023 - 9:39am
Source: 
Clinical Trials Arena
News Tags: 
Fosun Pharma
funding
malaria
artemether
lumefantrine
amodiaquine
Headline: 
Fosun Pharma secures $3.5m to accelerate development of malaria therapy
snippet: 

The Japan-based fund has invested in Fosun Pharma’s Phase III trial testing its triple artemisinin combination drug to accelerate the development and commercialisation.

Do Not Allow Advertisers to Use My Personal information